{
    "nct_id": "NCT04552275",
    "official_title": "Circulating Biomarkers of Hypo-Attenuated Leaflet Thickening After Transcatheter Aortic Valve Replacement",
    "inclusion_criteria": "1. Age > 65 years\n2. Subject with severe native AS or severe bioprosthetic valve degeneration\n3. Subject undergoing transfemoral TAVR using a Medtronic Evolut R, Evolut Pro or Evolut Pro+ transcatheter heart valve\nHealthy volunteers allowed\nMust have minimum age of 65 Years",
    "exclusion_criteria": "1. Chronic anticoagulation therapy\n2. Contraindication to systemic oral anticoagulation therapy\n3. Chronic kidney disease with EGFR<30 ml/min\n4. Bleeding diathesis or known coagulopathy\n5. Hypercoagulable state\n6. Life-expectancy <12 months due to other medical conditions (e.g., malignancy, severe Alzheimer's disease, etc.)\n7. The patient is currently participating in another investigational device or drug study that has not reached its primary objective/endpoint\n8. Pregnant, lactating, or planning pregnancy within next 12 months",
    "miscellaneous_criteria": ""
}